首页> 外文期刊>Cureus. >Chronic Inflammatory Demyelinating Polyradiculoneuropathy During the COVID-19 Pandemic: Telemedicine Limitations and Strategies for Improvement
【24h】

Chronic Inflammatory Demyelinating Polyradiculoneuropathy During the COVID-19 Pandemic: Telemedicine Limitations and Strategies for Improvement

机译:Covid-19大流行过程中的慢性炎症脱髓鞘治疗Polyradicul病变:远程医疗限制与改进策略

获取原文
           

摘要

Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) is a relapsing-remitting or progressive inflammatory neuropathy, which can present in a multitude of phenotypes. It can be a challenging condition to diagnose and requires thorough clinical evaluation and electrodiagnostic testing. With the outbreak of coronavirus disease in 2019 (COVID-19), large portions of the medical field converted to telemedicine to facilitate patient visits. We report a case of a 50-year-old female who was seen via video visit during the COVID-19 pandemic who was later diagnosed with CIDP and treated with intravenous immunoglobulins with improvement in clinical examination and electrodiagnostic testing. This case highlights the limitations of performing the neuromuscular examination via telemedicine.
机译:慢性炎症脱髓鞘(CIDP)是一种复发延迟或进行的炎症性神经病变,其可以存在于多种表型中。 它可能是诊断的具有挑战性的条件,并且需要彻底的临床评估和电源诊断。 随着2019年(Covid-19)的冠状病毒病爆发,大部分医疗领域转换为远程医疗,以促进患者访问。 我们举报了一个50岁的女性,通过在Covid-19大流行期间通过视频访问观看的案例,后来被诊断为CIDP并用静脉内免疫球蛋白治疗,并改善临床检查和电源测试。 这种情况突出了通过远程医疗进行神经肌肉检查的局限性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号